Tuesday May 14
Bioniche shareholders led by former Biovail execs renew bid to oust board
A group of dissident shareholders of Bioniche Life Sciences Inc. is launching a renewed bid to replace the company's board of directors.
Valeant Pharmaceuticals (VRX) Issues FY13 Earnings Guidance
Valeant Pharmaceuticals issued an update on its FY13 earnings guidance on Thursday morning.
Concerned Bioniche Shareholders Requisition Special Meeting of Shareholders to Replace the Board
The overwhelmingly positive reaction of our fellow shareholders to our open letter to the board has confirmed our view of the deep dissatisfaction of Bioniche's shareholders with the company's management and performance.
Frmr Biovail executives publicly reprimand Bioniche Life board, management
Unhappy shareholders at Bioniche Life Sciences Inc. are going public with efforts to reform the research and development company, saying its stock is worth just a fraction of what it once was.